Postprandial	O
anti-hyperglycemic	B:C2825141
activity	I:C2825141
of	O
marine	O
Streptomyces	O
coelicoflavus	I:C1656173
SRBVIT13	I:C1656173
mediated	O
gold	O
nanoparticles	O
in	O
streptozotocin	O
induced	O
diabetic	O
male	O
albino	O
Wister	I:C0034716
rats	I:C0034716

Postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
of	O
marine	O
Streptomyces	B:C1656173
coelicoflavus	I:C1656173
SRBVIT13	I:C1656173
mediated	O
gold	O
nanoparticles	O
in	O
streptozotocin	O
induced	O
diabetic	O
male	O
albino	O
Wister	I:C0034716
rats	I:C0034716

Postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
of	O
marine	O
Streptomyces	O
coelicoflavus	I:C1656173
SRBVIT13	I:C1656173
mediated	O
gold	B:C0018026
nanoparticles	O
in	O
streptozotocin	O
induced	O
diabetic	O
male	O
albino	O
Wister	I:C0034716
rats	I:C0034716

Postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
of	O
marine	O
Streptomyces	O
coelicoflavus	I:C1656173
SRBVIT13	I:C1656173
mediated	O
gold	O
nanoparticles	O
in	O
streptozotocin	B:C0038432
induced	O
diabetic	O
male	O
albino	O
Wister	I:C0034716
rats	I:C0034716

Postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
of	O
marine	O
Streptomyces	O
coelicoflavus	I:C1656173
SRBVIT13	I:C1656173
mediated	O
gold	O
nanoparticles	O
in	O
streptozotocin	O
induced	O
diabetic	B:C0011847
male	O
albino	O
Wister	I:C0034716
rats	I:C0034716

Postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
of	O
marine	O
Streptomyces	O
coelicoflavus	I:C1656173
SRBVIT13	I:C1656173
mediated	O
gold	O
nanoparticles	O
in	O
streptozotocin	O
induced	O
diabetic	O
male	O
albino	B:C0034716
Wister	I:C0034716
rats	I:C0034716

The	O
present	O
study	O
focuses	O
on	O
the	O
biosynthesis	O
of	O
gold	B:C0018026
nanoparticles	O
(	O
AuNPs	O
)	O
using	O
Streptomyces	O
coelicoflavus	I:C1656173
(	I:C1656173
S.	I:C1656173
coelicoflavus	I:C1656173
)	I:C1656173
SRBVIT13	I:C1656173
isolated	O
from	O
marine	O
salt	O
pan	O
soils	O
collected	O
from	O
Ongole	O
,	O
Andhra	O
Pradesh	O
,	O
India	O
.	O

The	O
present	O
study	O
focuses	O
on	O
the	O
biosynthesis	O
of	O
gold	O
nanoparticles	O
(	O
AuNPs	O
)	O
using	O
Streptomyces	B:C1656173
coelicoflavus	I:C1656173
(	I:C1656173
S.	I:C1656173
coelicoflavus	I:C1656173
)	I:C1656173
SRBVIT13	I:C1656173
isolated	O
from	O
marine	O
salt	O
pan	O
soils	O
collected	O
from	O
Ongole	O
,	O
Andhra	O
Pradesh	O
,	O
India	O
.	O

The	O
present	O
study	O
focuses	O
on	O
the	O
biosynthesis	O
of	O
gold	O
nanoparticles	O
(	O
AuNPs	O
)	O
using	O
Streptomyces	O
coelicoflavus	I:C1656173
(	I:C1656173
S.	I:C1656173
coelicoflavus	I:C1656173
)	I:C1656173
SRBVIT13	I:C1656173
isolated	O
from	O
marine	O
salt	O
pan	O
soils	O
collected	O
from	O
Ongole	O
,	O
Andhra	O
Pradesh	O
,	O
India	B:C0021201
.	O

The	O
biosynthesised	O
AuNPs	O
are	O
characterised	B:C1881968
by	O
UV	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
,	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
,	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
spectroscopy	I:C0206055
,	O
high	O
-	I:C2697588
resolution	I:C2697588
transmission	I:C2697588
electron	I:C2697588
microscopy	I:C2697588
and	O
energy	O
-	O
dispersive	O
X	O
-	O
ray	O
analysis	O
.	O

The	O
biosynthesised	O
AuNPs	O
are	O
characterised	O
by	O
UV	B:C0037812
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
,	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
,	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
spectroscopy	I:C0206055
,	O
high	O
-	I:C2697588
resolution	I:C2697588
transmission	I:C2697588
electron	I:C2697588
microscopy	I:C2697588
and	O
energy	O
-	O
dispersive	O
X	O
-	O
ray	O
analysis	O
.	O

The	O
biosynthesised	O
AuNPs	O
are	O
characterised	O
by	O
UV	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
,	O
X	B:C0043301
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
,	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
spectroscopy	I:C0206055
,	O
high	O
-	I:C2697588
resolution	I:C2697588
transmission	I:C2697588
electron	I:C2697588
microscopy	I:C2697588
and	O
energy	O
-	O
dispersive	O
X	O
-	O
ray	O
analysis	O
.	O

The	O
biosynthesised	O
AuNPs	O
are	O
characterised	O
by	O
UV	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
,	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
,	O
Fourier	B:C0206055
transform	I:C0206055
infrared	I:C0206055
spectroscopy	I:C0206055
,	O
high	O
-	I:C2697588
resolution	I:C2697588
transmission	I:C2697588
electron	I:C2697588
microscopy	I:C2697588
and	O
energy	O
-	O
dispersive	O
X	O
-	O
ray	O
analysis	O
.	O

The	O
biosynthesised	O
AuNPs	O
are	O
characterised	O
by	O
UV	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
,	O
X	O
-	I:C0043301
ray	I:C0043301
diffraction	I:C0043301
,	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
spectroscopy	I:C0206055
,	O
high	B:C2697588
-	I:C2697588
resolution	I:C2697588
transmission	I:C2697588
electron	I:C2697588
microscopy	I:C2697588
and	O
energy	O
-	O
dispersive	O
X	O
-	O
ray	O
analysis	O
.	O

Transmission	B:C0678118
electron	I:C0678118
microscopy	I:C0678118
study	O
suggests	O
that	O
the	O
biosynthesised	O
AuNPs	O
are	O
spherical	O
in	I:C0332501
shape	I:C0332501
within	O
a	O
size	O
range	O
of	O
12	O
-	O
20	O
nm	O
(	O
mean	O
diameter	O
as	O
14	O
nm	O
)	O
.	O

Transmission	O
electron	I:C0678118
microscopy	I:C0678118
study	O
suggests	O
that	O
the	O
biosynthesised	O
AuNPs	O
are	O
spherical	B:C0332501
in	I:C0332501
shape	I:C0332501
within	O
a	O
size	O
range	O
of	O
12	O
-	O
20	O
nm	O
(	O
mean	O
diameter	O
as	O
14	O
nm	O
)	O
.	O

Transmission	O
electron	I:C0678118
microscopy	I:C0678118
study	O
suggests	O
that	O
the	O
biosynthesised	O
AuNPs	O
are	O
spherical	O
in	I:C0332501
shape	I:C0332501
within	O
a	O
size	B:C0456389
range	O
of	O
12	O
-	O
20	O
nm	O
(	O
mean	O
diameter	O
as	O
14	O
nm	O
)	O
.	O

The	O
anti-type	B:C2825141
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	O
glucosidase	I:C0002272
and	O
α-	O
amylase	I:C3853624
enzyme	O
inhibition	I:C2248397
activity	I:C2248397
and	O
in	O
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
in	O
sucrose	O
and	O
glucose	O
-	O
loaded	O
streptozotocin	O
induced	O
diabetic	O
albino	O
Wister	I:C0034716
rats	I:C0034716
.	O

The	O
anti-type	O
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	B:C0002272
glucosidase	I:C0002272
and	O
α-	O
amylase	I:C3853624
enzyme	O
inhibition	I:C2248397
activity	I:C2248397
and	O
in	O
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
in	O
sucrose	O
and	O
glucose	O
-	O
loaded	O
streptozotocin	O
induced	O
diabetic	O
albino	O
Wister	I:C0034716
rats	I:C0034716
.	O

The	O
anti-type	O
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	O
glucosidase	I:C0002272
and	O
α-	B:C3853624
amylase	I:C3853624
enzyme	O
inhibition	I:C2248397
activity	I:C2248397
and	O
in	O
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
in	O
sucrose	O
and	O
glucose	O
-	O
loaded	O
streptozotocin	O
induced	O
diabetic	O
albino	O
Wister	I:C0034716
rats	I:C0034716
.	O

The	O
anti-type	O
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	O
glucosidase	I:C0002272
and	O
α-	O
amylase	I:C3853624
enzyme	B:C2248397
inhibition	I:C2248397
activity	I:C2248397
and	O
in	O
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
in	O
sucrose	O
and	O
glucose	O
-	O
loaded	O
streptozotocin	O
induced	O
diabetic	O
albino	O
Wister	I:C0034716
rats	I:C0034716
.	O

The	O
anti-type	O
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	O
glucosidase	I:C0002272
and	O
α-	O
amylase	I:C3853624
enzyme	O
inhibition	I:C2248397
activity	I:C2248397
and	O
in	B:C1515655
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
in	O
sucrose	O
and	O
glucose	O
-	O
loaded	O
streptozotocin	O
induced	O
diabetic	O
albino	O
Wister	I:C0034716
rats	I:C0034716
.	O

The	O
anti-type	O
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	O
glucosidase	I:C0002272
and	O
α-	O
amylase	I:C3853624
enzyme	O
inhibition	I:C2248397
activity	I:C2248397
and	O
in	O
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	B:C2825141
activity	I:C2825141
in	O
sucrose	O
and	O
glucose	O
-	O
loaded	O
streptozotocin	O
induced	O
diabetic	O
albino	O
Wister	I:C0034716
rats	I:C0034716
.	O

The	O
anti-type	O
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	O
glucosidase	I:C0002272
and	O
α-	O
amylase	I:C3853624
enzyme	O
inhibition	I:C2248397
activity	I:C2248397
and	O
in	O
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
in	O
sucrose	B:C0038636
and	O
glucose	O
-	O
loaded	O
streptozotocin	O
induced	O
diabetic	O
albino	O
Wister	I:C0034716
rats	I:C0034716
.	O

The	O
anti-type	O
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	O
glucosidase	I:C0002272
and	O
α-	O
amylase	I:C3853624
enzyme	O
inhibition	I:C2248397
activity	I:C2248397
and	O
in	O
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
in	O
sucrose	O
and	O
glucose	B:C0017725
-	O
loaded	O
streptozotocin	O
induced	O
diabetic	O
albino	O
Wister	I:C0034716
rats	I:C0034716
.	O

The	O
anti-type	O
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	O
glucosidase	I:C0002272
and	O
α-	O
amylase	I:C3853624
enzyme	O
inhibition	I:C2248397
activity	I:C2248397
and	O
in	O
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
in	O
sucrose	O
and	O
glucose	O
-	O
loaded	O
streptozotocin	B:C0038432
induced	O
diabetic	O
albino	O
Wister	I:C0034716
rats	I:C0034716
.	O

The	O
anti-type	O
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	O
glucosidase	I:C0002272
and	O
α-	O
amylase	I:C3853624
enzyme	O
inhibition	I:C2248397
activity	I:C2248397
and	O
in	O
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
in	O
sucrose	O
and	O
glucose	O
-	O
loaded	O
streptozotocin	O
induced	O
diabetic	B:C0011847
albino	O
Wister	I:C0034716
rats	I:C0034716
.	O

The	O
anti-type	O
II	I:C2825141
diabetes	I:C2825141
activity	I:C2825141
of	O
AuNPs	O
is	O
carried	O
out	O
by	O
testing	O
it	O
in	O
vitro	O
α-	O
glucosidase	I:C0002272
and	O
α-	O
amylase	I:C3853624
enzyme	O
inhibition	I:C2248397
activity	I:C2248397
and	O
in	O
vivo	I:C1515655
postprandial	O
anti-hyperglycemic	O
activity	I:C2825141
in	O
sucrose	O
and	O
glucose	O
-	O
loaded	O
streptozotocin	O
induced	O
diabetic	O
albino	B:C0034716
Wister	I:C0034716
rats	I:C0034716
.	O

AuNPs	O
has	O
shown	O
a	O
significant	O
inhibitory	B:C2248397
activity	I:C2248397
of	O
84.70	O
and	O
87.82	O
%	O
with	O
IC50	O
values	O
of	O
67.65	O
and	O
65.59	O
μg/	O
mL	O
to	O
α-glucosidase	O
and	O
α-	O
amylase	I:C3853624
enzymes	O
,	O
while	O
the	O
diabetic	O
rats	O
have	O
shown	O
significant	O
reduction	O
in	O
the	O
post	O
postprandial	O
blood	O
glucose	I:C0428554
level	I:C0428554
by	O
57.80	O
and	O
88.09	O
%	O
,	O
respectively	O
compared	O
with	O
control	O
group	O
after	O
AuNPs	O
treatment	O
at	O
the	O
concentration	O
of	O
300	O
and	O
600	O
mg	O
/	O
kg	O
body	O
weight	O
.	O

AuNPs	O
has	O
shown	O
a	O
significant	O
inhibitory	O
activity	I:C2248397
of	O
84.70	O
and	O
87.82	O
%	O
with	O
IC50	O
values	O
of	O
67.65	O
and	O
65.59	O
μg/	O
mL	O
to	O
α-glucosidase	B:C0002272
and	O
α-	O
amylase	I:C3853624
enzymes	O
,	O
while	O
the	O
diabetic	O
rats	O
have	O
shown	O
significant	O
reduction	O
in	O
the	O
post	O
postprandial	O
blood	O
glucose	I:C0428554
level	I:C0428554
by	O
57.80	O
and	O
88.09	O
%	O
,	O
respectively	O
compared	O
with	O
control	O
group	O
after	O
AuNPs	O
treatment	O
at	O
the	O
concentration	O
of	O
300	O
and	O
600	O
mg	O
/	O
kg	O
body	O
weight	O
.	O

AuNPs	O
has	O
shown	O
a	O
significant	O
inhibitory	O
activity	I:C2248397
of	O
84.70	O
and	O
87.82	O
%	O
with	O
IC50	O
values	O
of	O
67.65	O
and	O
65.59	O
μg/	O
mL	O
to	O
α-glucosidase	O
and	O
α-	B:C3853624
amylase	I:C3853624
enzymes	O
,	O
while	O
the	O
diabetic	O
rats	O
have	O
shown	O
significant	O
reduction	O
in	O
the	O
post	O
postprandial	O
blood	O
glucose	I:C0428554
level	I:C0428554
by	O
57.80	O
and	O
88.09	O
%	O
,	O
respectively	O
compared	O
with	O
control	O
group	O
after	O
AuNPs	O
treatment	O
at	O
the	O
concentration	O
of	O
300	O
and	O
600	O
mg	O
/	O
kg	O
body	O
weight	O
.	O

AuNPs	O
has	O
shown	O
a	O
significant	O
inhibitory	O
activity	I:C2248397
of	O
84.70	O
and	O
87.82	O
%	O
with	O
IC50	O
values	O
of	O
67.65	O
and	O
65.59	O
μg/	O
mL	O
to	O
α-glucosidase	O
and	O
α-	O
amylase	I:C3853624
enzymes	B:C0014442
,	O
while	O
the	O
diabetic	O
rats	O
have	O
shown	O
significant	O
reduction	O
in	O
the	O
post	O
postprandial	O
blood	O
glucose	I:C0428554
level	I:C0428554
by	O
57.80	O
and	O
88.09	O
%	O
,	O
respectively	O
compared	O
with	O
control	O
group	O
after	O
AuNPs	O
treatment	O
at	O
the	O
concentration	O
of	O
300	O
and	O
600	O
mg	O
/	O
kg	O
body	O
weight	O
.	O

AuNPs	O
has	O
shown	O
a	O
significant	O
inhibitory	O
activity	I:C2248397
of	O
84.70	O
and	O
87.82	O
%	O
with	O
IC50	O
values	O
of	O
67.65	O
and	O
65.59	O
μg/	O
mL	O
to	O
α-glucosidase	O
and	O
α-	O
amylase	I:C3853624
enzymes	O
,	O
while	O
the	O
diabetic	B:C0011847
rats	O
have	O
shown	O
significant	O
reduction	O
in	O
the	O
post	O
postprandial	O
blood	O
glucose	I:C0428554
level	I:C0428554
by	O
57.80	O
and	O
88.09	O
%	O
,	O
respectively	O
compared	O
with	O
control	O
group	O
after	O
AuNPs	O
treatment	O
at	O
the	O
concentration	O
of	O
300	O
and	O
600	O
mg	O
/	O
kg	O
body	O
weight	O
.	O

AuNPs	O
has	O
shown	O
a	O
significant	O
inhibitory	O
activity	I:C2248397
of	O
84.70	O
and	O
87.82	O
%	O
with	O
IC50	O
values	O
of	O
67.65	O
and	O
65.59	O
μg/	O
mL	O
to	O
α-glucosidase	O
and	O
α-	O
amylase	I:C3853624
enzymes	O
,	O
while	O
the	O
diabetic	O
rats	B:C0034693
have	O
shown	O
significant	O
reduction	O
in	O
the	O
post	O
postprandial	O
blood	O
glucose	I:C0428554
level	I:C0428554
by	O
57.80	O
and	O
88.09	O
%	O
,	O
respectively	O
compared	O
with	O
control	O
group	O
after	O
AuNPs	O
treatment	O
at	O
the	O
concentration	O
of	O
300	O
and	O
600	O
mg	O
/	O
kg	O
body	O
weight	O
.	O

AuNPs	O
has	O
shown	O
a	O
significant	O
inhibitory	O
activity	I:C2248397
of	O
84.70	O
and	O
87.82	O
%	O
with	O
IC50	O
values	O
of	O
67.65	O
and	O
65.59	O
μg/	O
mL	O
to	O
α-glucosidase	O
and	O
α-	O
amylase	I:C3853624
enzymes	O
,	O
while	O
the	O
diabetic	O
rats	O
have	O
shown	O
significant	O
reduction	O
in	O
the	O
post	O
postprandial	O
blood	B:C0428554
glucose	I:C0428554
level	I:C0428554
by	O
57.80	O
and	O
88.09	O
%	O
,	O
respectively	O
compared	O
with	O
control	O
group	O
after	O
AuNPs	O
treatment	O
at	O
the	O
concentration	O
of	O
300	O
and	O
600	O
mg	O
/	O
kg	O
body	O
weight	O
.	O

Hence	O
,	O
this	O
biosynthesised	O
AuNPs	O
might	O
be	O
useful	O
in	O
combating	O
type	B:C0011860
II	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
for	O
the	O
betterment	O
of	O
human	O
life	O
.	O

Hence	O
,	O
this	O
biosynthesised	O
AuNPs	O
might	O
be	O
useful	O
in	O
combating	O
type	O
II	I:C0011860
diabetes	I:C0011860
mellitus	I:C0011860
for	O
the	O
betterment	O
of	O
human	B:C0086418
life	O
.	O

